Platelet Glycoprotein Ⅵ: A Novel Target for Antithrombotic Therapy in Cardiovascular Disease
Abstract. Platelets play an important role in thrombosis caused by acute coronary syndrome and stroke. As the main platelet collagen receptor, platelet glycoprotein Ⅵ (GPⅥ) is an important modulator in the activation and aggregation of platelets at vascular injury sites. Recently, GPⅥ has been ident...
Saved in:
| Main Authors: | Menglu Liu, Xueyan Zhao, Hanjia Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2024-12-01
|
| Series: | Cardiology Discovery |
| Online Access: | http://journals.lww.com/10.1097/CD9.0000000000000137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Platelet surface receptor glycoprotein VI-dimer is overexpressed in stroke: The Glycoprotein VI in Stroke (GYPSIE) study results.
by: Isuru Induruwa, et al.
Published: (2022-01-01) -
The role of modern antithrombotic agents in cardiovascular disease prevention
by: O. M. Drapkina, et al.
Published: (1970-01-01) -
Translating proof-of-concept for platelet slip into improved antithrombotic therapeutic regimens
by: Scott J. Denardo, et al.
Published: (2024-12-01) -
Osteoporosis and antithrombotic therapy
by: N. V. Brailova, et al.
Published: (2021-06-01) -
Platelet glycoprotein VI promotes folic acid-induced acute kidney injury through interaction with tubular epithelial cell-derived galectin-3
by: Ya-Wei Guo, et al.
Published: (2025-03-01)